Guide — Mental Health
Opioid Withdrawal Nursing Care
Opioid withdrawal is miserable but rarely fatal — the opposite of alcohol. The clinical work is comfort, accurate COWS scoring, starting evidence-based medication-assisted treatment without triggering precipitated withdrawal, and keeping the overdose risk after detox front of mind.
8 min read · Mental Health
Educational use only. Medication-assisted treatment regimens and COWS-based dosing are provider-directed and regulated; this guide covers nursing care concepts. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
Overview
Opioid withdrawal is the body’s rebound when chronic opioid use stops — uncomfortable and intensely craving-driven, but not directly life-threatening in healthy adults (unlike alcohol or benzodiazepine withdrawal). Onset depends on the drug’s half-life: short-acting opioids (heroin, oxycodone) within 8–24 hours, methadone over several days.
The real dangers sit on either side of withdrawal: aspiration and dehydration from severe vomiting and diarrhea, and — critically — the sharply elevated overdose risk if the person relapses after detox, because tolerance falls fast. That single fact reframes the goal from “get them off opioids” to “keep them alive and in treatment.”
Assessment Findings
Opioid withdrawal looks like a severe flu with autonomic overdrive: dilated pupils, yawning, lacrimation and rhinorrhea, piloerection (“cold turkey” gooseflesh), sweating, muscle aches and bone pain, abdominal cramping, nausea, vomiting, diarrhea, restlessness, anxiety, and powerful craving. Vital signs run high — tachycardia, hypertension — and the patient is exhausted but unable to rest.
The COWS (Clinical Opiate Withdrawal Scale) quantifies eleven signs and symptoms to grade severity and — importantly — to confirm a patient is in objective withdrawal before buprenorphine is started.
Medication-Assisted Treatment (MAT)
Methadone
Full opioid agonist; suppresses withdrawal and craving. Dispensed through regulated programs for addiction treatment. Watch QT prolongation and respiratory depression, especially with other CNS depressants.
Buprenorphine (often with naloxone)
Partial agonist with a ceiling effect (safer in overdose). The catch: because it binds tightly and only partially activates the receptor, giving it while full agonists are still on board can precipitate abrupt, severe withdrawal. It is started only once the patient is in objective withdrawal (an adequate COWS score).
Naltrexone
Opioid antagonist for relapse prevention — blocks the effect. The patient must be fully detoxed first (giving it too early precipitates withdrawal). Available as a monthly injection that removes the daily-adherence problem.
Adjuncts & naloxone
Clonidine eases autonomic symptoms; antiemetics, antidiarrheals, and NSAIDs treat the rest. Naloxone reverses overdose (respiratory depression, pinpoint pupils) — every at-risk patient should go home with it and know how to use it.
Nursing Priorities
Score before you dose
Use COWS to confirm objective withdrawal before buprenorphine — starting too early is the classic precipitated-withdrawal error.
Comfort and hydration
Fluids and electrolytes for GI losses, symptom-targeted medications, a calm environment, and reassurance that the worst passes within days.
Overdose-prevention teaching is care
Prescribe and teach naloxone, warn explicitly that tolerance drops during abstinence so a previous dose can now be fatal, and connect to ongoing MAT before discharge.
Treat pain honestly
Patients on MAT still have real pain and real surgeries; their baseline opioid needs are higher, not lower. Don’t withhold legitimate analgesia out of suspicion.
Therapeutic Communication Considerations
Stigma is a clinical risk here: patients who feel judged disengage and disappear from treatment, where the overdose risk lives. Use person-first language (“person with opioid use disorder,” not “addict”), treat craving as a symptom rather than a character flaw, and frame MAT as evidence-based treatment of a chronic disease — not “substituting one drug for another.”
Validate the discomfort honestly and stay present. Trust earned during withdrawal is what keeps someone in treatment afterward.
Patient Education
Teach naloxone use to the patient and a support person, and that reduced tolerance after any abstinence makes relapse especially dangerous. Explain how MAT works and that staying on it long-term is protective, not a failure. Reinforce that recurrence is common in chronic disease and is a reason to re-engage, not to give up — and provide concrete numbers and resources for that re-engagement.
NCLEX Pearls
- ✦Opioid withdrawal is rarely fatal itself; the lethal risk is overdose after tolerance drops — naloxone teaching is essential.
- ✦Confirm objective withdrawal (COWS) before buprenorphine — giving it too soon precipitates severe withdrawal.
- ✦Naltrexone requires full detox first; it’s an antagonist for relapse prevention.
- ✦Dilated pupils, yawning, rhinorrhea, piloerection, GI distress — the classic withdrawal cluster.
- ✦Overdose triad: respiratory depression, pinpoint pupils, decreased consciousness → naloxone.
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with American Psychiatric Association (DSM-5-TR) · American Psychiatric Nurses Association (APNA) · SAMHSA. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →